Latest Market Challenges News

Australian Foundation Investment Company (ASX:AFI) posted a 3% increase in net profit for FY26, holding dividends steady with a special payout amid portfolio underperformance against the ASX 200.

EDU Holdings has delivered record first-half 2026 results, driven by a 57% jump in Higher Education enrolments at Ikon, lifting revenue by 48% and profit before tax by 57%.

Atturra reports FY26 underlying EBITDA in line with guidance despite softer revenue and announces a significant non-cash goodwill impairment tied to government contracts. The company plans substantial FY27 investment in AI, ERP, and education technology to drive organic growth.

Vysarn Limited reported a record FY26 with NPBT of $20.9 million and operational revenue of $140.1 million, while completing the $50 million NewGround acquisition that boosts pro forma EPS by 26.7%.

MyEco Group’s FY26 retail sales edged up 0.8% to $15.8 million, powered by a 22.7% surge in Australian branded product sales and a successful launch of certified recycled bin liners at Woolworths.

Ryman Healthcare reported steady retirement living sales in Q1 FY27 with a 7% rise in net resales, buoyed by serviced apartments. The company remains on track for FY27 build targets and sees robust aged care occupancy despite housing market headwinds.

Nine Entertainment has locked in exclusive free-to-air and streaming rights for NRL and NRLW matches from 2028 to 2034, reinforcing its dominance in Australian sports broadcasting and promising continued audience growth.

Helia Group has renewed its exclusive Lenders Mortgage Insurance contract with ING Bank Australia for four years from July 2026, preserving a significant revenue stream representing about 20% of its FY25 premiums.

Prophecy International has launched a sweeping global organisational restructure that will slash its workforce by approximately 48%, aiming to realign operations and reduce costs ahead of its FY26 results.

Saluda Medical has obtained FDA approval for its CAP24 surgical paddle lead, a first-of-its-kind device designed for closed-loop spinal cord stimulation, poised to broaden its US market reach and engage new surgical specialties.

ArborGen Holdings reported a solid FY26 with record revenue driven by Brazil expansion and a 31% EBITDA increase, offsetting a challenging US market. Leadership changes and operational discipline mark the company’s path forward.

GTN Limited projects a sharp fall in FY26 earnings amid tough market conditions but signals a hefty dividend and a rebound in FY27 EBITDA.